Sterile Intravenous (IV) Solution Market was valued at USD 5.2 Billion in 2022 and is projected to reach USD 8.0 Billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030.
The sterile intravenous (IV) solution market is a critical component of global healthcare, providing essential fluids and nutrients to patients unable to consume them orally. Recent events, such as natural disasters impacting production facilities, have highlighted the market's vulnerabilities and underscored the need for robust supply chains. This article delves into the current state of the market, challenges faced, and future prospects.
Intravenous solutions are sterile fluids administered directly into a patient's bloodstream to prevent or treat dehydration, electrolyte imbalances, and provide nutrients. They are indispensable in various medical settings, including surgeries, chemotherapy, and emergency care.
As of 2023, the global intravenous solutions market was valued at approximately USD 12.9 billion. Projections indicate a compound annual growth rate (CAGR) of 8% from 2024 to 2030, driven by factors such as an aging population, rising prevalence of chronic diseases, and increasing cases of malnutrition. Source
In India, the intravenous solutions market was valued at INR 171.44 billion in 2024, with expectations to reach INR 351.37 billion by 2034, reflecting a CAGR of 8.3%. This growth is attributed to the expansion of healthcare infrastructure and government initiatives aimed at improving public health. Source
In September 2024, Hurricane Helene caused significant flooding at Baxter International's manufacturing facility in Marion, North Carolina. This plant is responsible for producing 60% of the intravenous fluids used in U.S. hospitals. The flooding led to a substantial shortage of IV solutions nationwide, forcing healthcare providers to ration supplies and delay elective procedures. Source
The closure of Baxter's facility exposed the fragility of the medical supply chain, particularly when a single manufacturer holds a significant market share. Hospitals reported receiving less than half of their usual IV fluid orders, highlighting the need for diversification in production and sourcing. Source
In response to the shortages, Baxter International began importing IV solutions from its international facilities in Thailand and Singapore to alleviate the domestic shortfall. Concurrently, B. Braun Medical announced plans to increase production of IV fluids by 20% at its California and Florida facilities, aiming to add over 30 million units annually. Source
The U.S. Food and Drug Administration (FDA) collaborated with manufacturers to expedite the approval of alternative production sites and extended the shelf life of existing IV products to mitigate the shortage. Additionally, the Department of Health and Human Services invoked the Defense Production Act to prioritize the allocation of necessary materials for IV fluid production. Source
The intravenous solutions market is poised for significant growth, driven by increasing healthcare needs globally. The rising prevalence of chronic diseases, advancements in medical treatments, and expanding healthcare infrastructure in emerging economies contribute to this positive outlook.
Recent disruptions have prompted industry stakeholders to re-evaluate and strengthen supply chain strategies. Diversifying manufacturing locations, increasing inventory buffers, and investing in local production capabilities are measures being considered to enhance resilience against future disruptions.
The sterile intravenous solution market plays a vital role in global healthcare delivery. While recent challenges have tested the industry's robustness, they have also provided valuable lessons. By addressing supply chain vulnerabilities and embracing growth opportunities, the market is well-positioned to meet the evolving needs of healthcare systems worldwide.
Download Full PDF Sample Copy of Global Sterile Intravenous (IV) Solution Report @ https://www.verifiedmarketreports.com/download-sample/?rid=822960&utm_source=Pulse-Feb&utm_medium=231
B. Braun Medical Inc
Technoflex
Baxter International
ICU Medical
Inc Mckesson
Amsino
Wallcur
Hebei Guangren Pharmaceutical Technology
Jiangsu Hengfengqiang Biotechnology
Hospira
Jiangsu Hengfengqiang Biotechnology
Hospira
Xi'an Libang Alliance Enterprise Management
Livzon Group
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=822960&utm_source=Pulse-Feb&utm_medium=231
Growing demand for below applications around the world has had a direct impact on the growth of the Global Sterile Intravenous (IV) Solution Market
Medications
NutritionNutrition
Blood-based Products
Others
Based on Types the Market is categorized into Below types that held the largest Sterile Intravenous (IV) Solution market share In 2023.
Crystalloids
Colloids
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/sterile-intravenous-iv-solution-market/
1. Introduction of the Global Sterile Intravenous (IV) Solution Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Sterile Intravenous (IV) Solution Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Sterile Intravenous (IV) Solution Market, By Type
6. Global Sterile Intravenous (IV) Solution Market, By Application
7. Global Sterile Intravenous (IV) Solution Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Sterile Intravenous (IV) Solution Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/